News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,819 Results
Type
Article (39589)
Company Profile (247)
Press Release (655983)
Section
Business (204115)
Career Advice (2008)
Deals (35421)
Drug Delivery (94)
Drug Development (81007)
Employer Resources (172)
FDA (16150)
Job Trends (14842)
News (345062)
Policy (32509)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2546)
Accelerated approval (2)
Adcomms (20)
Allergies (80)
Alliances (49368)
ALS (81)
Alzheimer's disease (1346)
Antibody-drug conjugate (ADC) (107)
Approvals (16151)
Artificial intelligence (225)
Autoimmune disease (13)
Automation (14)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (100)
Biotechnology (175)
Bladder cancer (56)
Brain cancer (24)
Breast cancer (245)
Cancer (1957)
Cardiovascular disease (147)
Career advice (1674)
Career pathing (29)
CAR-T (139)
Cell therapy (392)
Cervical cancer (17)
Clinical research (65645)
Collaboration (757)
Compensation (446)
Complete response letters (18)
COVID-19 (2581)
CRISPR (34)
C-suite (203)
Cystic fibrosis (98)
Data (1896)
Decentralized trials (2)
Denatured (16)
Depression (36)
Diabetes (241)
Diagnostics (6334)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (109)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (84)
Earnings (86119)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (111571)
Executive appointments (626)
FDA (17235)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (681)
Gene editing (94)
Generative AI (18)
Gene therapy (270)
GLP-1 (679)
Government (4381)
Grass and pollen (4)
Guidances (48)
Healthcare (18806)
Huntington's disease (22)
IgA nephropathy (21)
Immunology and inflammation (101)
Indications (26)
Infectious disease (2709)
Inflammatory bowel disease (131)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (83)
Interviews (311)
IPO (16485)
IRA (41)
Job creations (3628)
Job search strategy (1423)
Kidney cancer (9)
Labor market (34)
Layoffs (449)
Leadership (15)
Legal (7904)
Liver cancer (70)
Lung cancer (287)
Lymphoma (129)
Machine learning (2)
Management (58)
Manufacturing (264)
MASH (59)
Medical device (13313)
Medtech (13318)
Mergers & acquisitions (19399)
Metabolic disorders (619)
Multiple sclerosis (67)
NASH (16)
Neurodegenerative disease (75)
Neuropsychiatric disorders (24)
Neuroscience (1806)
NextGen: Class of 2025 (6514)
Non-profit (4477)
Northern California (2385)
Now hiring (37)
Obesity (336)
Opinion (201)
Ovarian cancer (71)
Pain (75)
Pancreatic cancer (76)
Parkinson's disease (130)
Partnered (18)
Patents (199)
Patient recruitment (93)
Peanut (46)
People (57052)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20443)
Phase II (28910)
Phase III (21541)
Pipeline (959)
Podcasts (45)
Policy (108)
Postmarket research (2563)
Preclinical (8650)
Press Release (64)
Prostate cancer (91)
Psychedelics (31)
Radiopharmaceuticals (243)
Rare diseases (350)
Real estate (5900)
Recruiting (65)
Regulatory (22116)
Reports (46)
Research institute (2317)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (61)
Series A (120)
Series B (77)
Service/supplier (11)
Sickle cell disease (49)
Southern California (2058)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3576)
State (2)
Stomach cancer (12)
Supply chain (59)
The Weekly (26)
United States (20831)
Vaccines (654)
Venture capitalists (37)
Webinars (12)
Weight loss (224)
Women's health (33)
Worklife (15)
Date
Today (69)
Last 7 days (564)
Last 30 days (2636)
Last 365 days (33508)
2025 (7624)
2024 (35224)
2023 (40086)
2022 (51177)
2021 (55713)
2020 (54085)
2019 (46544)
2018 (35021)
2017 (32128)
2016 (31483)
2015 (37553)
2014 (31318)
2013 (26349)
2012 (28574)
2011 (29271)
2010 (27331)
Location
Africa (717)
Alabama (49)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (37689)
Australia (6161)
California (5437)
Canada (1853)
China (465)
Colorado (244)
Connecticut (256)
Delaware (123)
Europe (80802)
Florida (809)
Georgia (190)
Idaho (57)
Illinois (488)
India (23)
Indiana (288)
Iowa (9)
Japan (138)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (822)
Massachusetts (4085)
Michigan (208)
Minnesota (366)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1545)
New Mexico (28)
New York (1560)
North Carolina (908)
North Dakota (7)
Northern California (2385)
Ohio (190)
Oklahoma (14)
Oregon (33)
Pennsylvania (1237)
Puerto Rico (9)
Rhode Island (26)
South America (1094)
South Carolina (18)
South Dakota (1)
Southern California (2058)
Tennessee (92)
Texas (809)
Utah (163)
Virginia (127)
Washington D.C. (57)
Washington State (506)
West Virginia (3)
Wisconsin (48)
695,819 Results for "grail inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Illumina completes the divestiture of GRAIL
Illumina, Inc. announced the successful completion of the spin-off of GRAIL. This milestone follows the company’s previously announced plans to divest GRAIL, and GRAIL is now a public and independent company.
June 24, 2024
·
6 min read
Bio NC
GRAIL to Begin Trading on the Nasdaq Stock Exchange
GRAIL, Inc. announced its spin-off from Illumina is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol “GRAL” as of tomorrow, June 25, 2024.
June 24, 2024
·
9 min read
Press Releases
GRAIL to Announce Fourth Quarter 2024 Financial Results
February 12, 2025
·
1 min read
Press Releases
GRAIL and Quest Diagnostics Provide GRAIL’s Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System
February 13, 2025
·
9 min read
Biotech Beach
Illumina Board of Directors approves spin-off of GRAIL; declares spin-off dividend of GRAIL shares
Illumina, Inc. announced that its Board of Directors has approved the spin-off of GRAIL.
June 3, 2024
·
6 min read
Press Releases
GRAIL to Present at TD Cowen 45th Annual Health Care Conference
February 24, 2025
·
1 min read
Press Releases
GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results
February 21, 2025
·
18 min read
GRAIL to Host Capital Markets Day
GRAIL Leadership to Outline Early Cancer Detection Market Opportunity, Business Strategy, and Financial Profile MENLO PARK, Calif.--( BUSINESS WIRE )-- GRAIL, LLC., a healthcare company whose mission is to detect cancer early when it can be cured, today will host a virtual Capital Markets Day. Members from GRAIL’s management team will outline growth drivers for Galleri ® , a clinically validated, commercially available multi-cancer early detection test, as well as the Company’s scien
May 13, 2024
·
9 min read
Press Releases
GRAIL to Participate in Upcoming Investor Conferences
November 19, 2024
·
1 min read
Deals
Grail to Begin Trading on Nasdaq as Illumina Completes Divestiture
After being spun off of sequencing giant Illumina, Grail on Tuesday is set to start trading on the Nasdaq Global Select Market following a years-long antitrust battle with regulators.
June 25, 2024
·
2 min read
·
Tristan Manalac
1 of 69,582
Next
